USE OF CARBONIC ANHYDRASE II FOR PRODUCING A DRUG

The present invention relates to the field of biomedicine. Specifically, the present invention relates to the use of carbonic anhydrase II for producing a drug for preventing and/or treating damage caused by ischemia, ischemia followed by reperfusion or a toxin, acute failure or rejection of an orga...

Full description

Saved in:
Bibliographic Details
Main Authors VINAS, JOSE LUIS, HOTTER CORRIPIO, GEORGINA, SOLA MARTINEZ, ANNA
Format Patent
LanguageEnglish
French
German
Published 16.05.2012
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of biomedicine. Specifically, the present invention relates to the use of carbonic anhydrase II for producing a drug for preventing and/or treating damage caused by ischemia, ischemia followed by reperfusion or a toxin, acute failure or rejection of an organ transplant, preferably of a kidney. In a preferred embodiment, the toxin is cisplatin.
Bibliography:Application Number: EP20100796766